These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3677034)

  • 1. Photodynamic therapy in the management of resistant lower urinary tract carcinoma.
    Nseyo UO; Dougherty TJ; Sullivan L
    Cancer; 1987 Dec; 60(12):3113-9. PubMed ID: 3677034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder.
    Walther MM; Delaney TF; Smith PD; Friauf WS; Thomas GF; Shawker TH; Vargas MP; Choyke PL; Linehan WM; Abraham EH; Okunieff PG; Glatstein E
    Urology; 1997 Aug; 50(2):199-206. PubMed ID: 9255289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experience.
    Nseyo UO; DeHaven J; Dougherty TJ; Potter WR; Merrill DL; Lundahl SL; Lamm DL
    J Clin Laser Med Surg; 1998 Feb; 16(1):61-8. PubMed ID: 9728133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.
    Nseyo UO; Shumaker B; Klein EA; Sutherland K
    J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy in the management of bladder cancer.
    Nseyo UO
    J Clin Laser Med Surg; 1996 Oct; 14(5):271-80. PubMed ID: 9612193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium.
    Manyak MJ; Ogan K
    J Endourol; 2003 Oct; 17(8):633-9. PubMed ID: 14622483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole bladder photodynamic therapy for orthotopic superficial bladder cancer in rats: a study of intravenous and intravesical administration of photosensitizers.
    Xiao Z; Brown K; Tulip J; Moore RB
    J Urol; 2003 Jan; 169(1):352-6. PubMed ID: 12478188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integral photodynamic therapy of superficial bladder tumors with special reference to carcinoma in situ.
    Hisazumi H; Naito K; Uchibayashi T; Hirata A; Komatsu K
    Scand J Urol Nephrol Suppl; 1991; 138():161-5. PubMed ID: 1785000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy--A potential bladder sparing option for high risk non-muscle invasive bladder cancer.
    Lee LS; Thong PS; Olivo M; Chin WW; Ramaswamy B; Kho KW; Lim PL; Lau WK
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):213-20. PubMed ID: 21112542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?].
    Kriegmair M; Waidelich R; Baumgartner R; Lumper W; Ehsan A; Hofstetter A
    Urologe A; 1994 Jul; 33(4):276-80. PubMed ID: 7941172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole bladder photodynamic therapy for transitional cell carcinoma of bladder.
    Nseyo UO; Dougherty TJ; Boyle DG; Potter WR; Wolf R; Huben R; Pontes JE
    Urology; 1985 Sep; 26(3):274-80. PubMed ID: 2930927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
    Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
    J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Photodynamic therapy of superficial bladder tumors].
    Misaki T; Hisazumi H; Hirata A; Kunimi K; Yamamoto H; Amano T; Kumaki O; Koshida K; Nishino A; Nakazima K
    Hinyokika Kiyo; 1986 Dec; 32(12):1941-8. PubMed ID: 3825831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder.
    Canda AE; Tuzel E; Mungan MU; Yorukoglu K; Kirkali Z
    Eur Urol; 2004 Apr; 45(4):465-9; discussion 469-70. PubMed ID: 15041110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integral laser photodynamic treatment of refractory multifocal bladder tumors.
    Naito K; Hisazumi H; Uchibayashi T; Amano T; Hirata A; Komatsu K; Ishida T; Miyoshi N
    J Urol; 1991 Dec; 146(6):1541-5. PubMed ID: 1942336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of whole bladder dihematoporphyrin ether photodynamic therapy.
    Harty JI; Amin M; Wieman TJ; Tseng MT; Ackerman D; Broghamer W
    J Urol; 1989 Jun; 141(6):1341-6. PubMed ID: 2524602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The photodynamic effect of a pulsed dye laser on human bladder carcinoma cells in vitro.
    Pope AJ; Masters JR; MacRobert AJ
    Urol Res; 1990; 18(4):267-70. PubMed ID: 2145683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin.
    Kamuhabwa AA; Roskams T; D'Hallewin MA; Baert L; Van Poppel H; de Witte PA
    Int J Cancer; 2003 Nov; 107(3):460-7. PubMed ID: 14506748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy.
    Nseyo UO
    Urol Clin North Am; 1992 Aug; 19(3):591-9. PubMed ID: 1386168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
    Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
    Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.